Literature DB >> 21135593

Cardiovascular-associated disease in an addicted population: an observation study.

Daniela Demarie1, Giovanna Marletta, Massimo Imazio, Carolina Cappa, Silvia Ferro, Roberto Compostino, Enrico De Vivo, Rita Trinchero, Emanuele Bignamini.   

Abstract

BACKGROUND: Illicit drugs such as cocaine, and methadone can induce acquired long QT syndrome.
OBJECTIVE: The aim of this study was to evaluate the prevalence of cardiovascular disease and to assess the risk of torsades de pointes in substance abuse patients either with methadone or buprenorphine maintenance therapy, or without any specific therapy for opiate addiction.
METHODS: From November 2008 to December 2009, 190 patients (153 men, mean age 38.2 years, 22-56 years) with a substance use disorder according to DSM IV TR criteria were included in the study. All patients underwent blood tests, serial electrocardiogram (ECG) and, when necessary, additional testing, including echocardiogram, exercise test and Holter monitoring. Age and sex-matched healthy controls were also evaluated and compared with the cases.
RESULTS: One hundred and twenty-five patients (65.7%) had associated diseases. The prevalence of coronary artery disease and hypertension was, respectively, 2.1 and 5.2% in the addicted population. The percentage of abnormal ECGs was 34.2% in the addicted population and 4.7% in the nonaddicted population (P < 0.001). Twenty-five addicted patients had a QT interval prolongation (10 patients ≥ 480 ms). There were no sudden deaths or major cardiac events during the observation period.
CONCLUSIONS: Our results indicate that the QT interval prolongation is not a negative prognostic marker in the addicted population, even with associated diseases. ECG should be performed when other drugs potentially prolonging QT interval are associated. Substance abuse patients should be followed by multidisciplinary teams, and blood tests and ECGs should be performed regularly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21135593     DOI: 10.2459/JCM.0b013e32834033f2

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  8 in total

1.  Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial.

Authors:  Michael D Stein; Megan E Kurth; Katherine M Sharkey; Bradley J Anderson; Richard P Corso; Richard P Millman
Journal:  Drug Alcohol Depend       Date:  2011-07-27       Impact factor: 4.492

Review 2.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

3.  Sitting Time, But Not Level Of Physical Activity, Is Associated With Depression In Methadone-Maintained Smokers.

Authors:  Michael D Stein; Celeste M Caviness; Bradley J Anderson; Ana Abrantes
Journal:  Ment Health Phys Act       Date:  2013-03-01

4.  Minimum recommended physical activity, and perceived barriers and benefits of exercise in methadone maintained persons.

Authors:  Celeste M Caviness; Jessica L Bird; Bradley J Anderson; Ana M Abrantes; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2012-11-28

5.  Prescription medication exchange patterns among methadone maintenance patients.

Authors:  Celeste M Caviness; Bradley J Anderson; Marcel A de Dios; Megan Kurth; Michael Stein
Journal:  Drug Alcohol Depend       Date:  2012-07-31       Impact factor: 4.492

6.  Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

Authors:  Hsin-Ya Lee; Jih-Heng Li; Li-Tzy Wu; Jin-Song Wu; Cheng-Fang Yen; Hsin-Pei Tang
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-03-20

7.  Survey of the effect of opioid abuse on the extent of coronary artery diseases.

Authors:  B Rahimi Darabad; J Vatandust; M M Pourmousavi Khoshknab; M Hajahmadi Poorrafsanjani
Journal:  Glob J Health Sci       Date:  2014-09-18

Review 8.  The Impact of Opioids on Cardiac Electrophysiology.

Authors:  Erich F Wedam; Mark C Haigney
Journal:  Curr Cardiol Rev       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.